Literature DB >> 9301521

Interferon-regulatory factors during development of CD4 and CD8 thymocytes.

A K Simon1, M Desrois, A M Schmitt-Verhulst.   

Abstract

Selection events in the thymus occur at the double-positive CD4+ CD8+ (DP) developmental stage leading either to further differentiation of the CD4+ and CD8+ lineages or to deletion. The interferon-regulatory factor IRF-1 has been implicated in signalling for T-cell death and also in CD8+ thymic differentiation. IRF-1 is an activator and IRF-2 a repressor of gene transcription regulated by type 1 interferons (IFN). To evaluate the role of IRF-1 and IRF-2 in the differentiation of CD4 and CD8 thymocytes, we analysed their DNA-binding activity before and after antigenic stimulation at different stages of thymic development and in peripheral T cells. Unseparated, double-positive and single-positive thymocytes as well as peripheral T lymphocytes from mice transgenic (tg) for a T-cell receptor (TCR), restricted either by major histocompatibility complex class I or class II, were stimulated by their nominal antigen. Our results demonstrate that the DNA-binding activity of IRF-2 and, weakly, that of IRF-1 are inducible in total thymocytes in response to antigen. There is no induction of IRF-1/IRF-2 binding activity at the double-positive stage of thymic development in the MHC class II-restricted model whereas in the MHC class I-restricted model IRF-1/IRF-2 activity is induced weakly. At the single-positive stage, antigen induces the IRF-1/IRF-2 DNA binding in both CD4+ and CD8+ thymocytes, but not in mature lymphocytes from the periphery. This pattern of expression suggests that IRF-1/IRF-2 binding activities resulting from antigen stimulation are developmentally regulated. No evidence for a selective role of IRF-1 in the development of the CD8+ lineage was found, however.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301521      PMCID: PMC1364001          DOI: 10.1046/j.1365-2567.1997.00271.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE).

Authors:  T Matsuyama; A Grossman; H W Mittrücker; D P Siderovski; F Kiefer; T Kawakami; C D Richardson; T Taniguchi; S K Yoshinaga; T W Mak
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

2.  Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes.

Authors:  H Harada; T Fujita; M Miyamoto; Y Kimura; M Maruyama; A Furia; T Miyata; T Taniguchi
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

3.  T-cell apoptosis detected in situ during positive and negative selection in the thymus.

Authors:  C D Surh; J Sprent
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

4.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

5.  Human Fas ligand: gene structure, chromosomal location and species specificity.

Authors:  T Takahashi; M Tanaka; J Inazawa; T Abe; T Suda; S Nagata
Journal:  Int Immunol       Date:  1994-10       Impact factor: 4.823

6.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme.

Authors:  K Kuida; J A Lippke; G Ku; M W Harding; D J Livingston; M S Su; R A Flavell
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

7.  Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

Authors:  N Tanaka; M Ishihara; M Kitagawa; H Harada; T Kimura; T Matsuyama; M S Lamphier; S Aizawa; T W Mak; T Taniguchi
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

8.  Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells.

Authors:  W Y Ho; M P Cooke; C C Goodnow; M M Davis
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

9.  Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements.

Authors:  T Fujita; J Sakakibara; Y Sudo; M Miyamoto; Y Kimura; T Taniguchi
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

10.  Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes.

Authors:  L F Reis; H Ruffner; G Stark; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  1 in total

1.  Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors.

Authors:  Büşra Erarslan-Uysal; Joachim B Kunz; Tobias Rausch; Paulina Richter-Pechańska; Ianthe Aem van Belzen; Viktoras Frismantas; Beat Bornhauser; Diana Ordoñez-Rueada; Malte Paulsen; Vladimir Benes; Martin Stanulla; Martin Schrappe; Gunnar Cario; Gabriele Escherich; Kseniya Bakharevich; Renate Kirschner-Schwabe; Cornelia Eckert; Tsvetomir Loukanov; Matthias Gorenflo; Sebastian M Waszak; Jean-Pierre Bourquin; Martina U Muckenthaler; Jan O Korbel; Andreas E Kulozik
Journal:  EMBO Mol Med       Date:  2020-08-05       Impact factor: 12.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.